Unknown

Dataset Information

Fundoscopy-directed genetic testing to re-evaluate negative whole exome sequencing results.


ABSTRACT:

Background

Whole exome sequencing (WES) allows for an unbiased search of the genetic cause of a disease. Employing it as a first-tier genetic testing can be favored due to the associated lower incremental cost per diagnosis compared to when using it later in the diagnostic pathway. However, there are technical limitations of WES that can lead to inaccurate negative variant callings. Our study presents these limitations through a re-evaluation of negative WES results using subsequent tests primarily driven by fundoscopic findings. These tests included targeted gene testing, inherited retinal gene panels, whole genome sequencing (WGS), and array comparative genomic hybridization.

Results

Subsequent genetic testing guided by fundoscopy findings identified the following variant

SUBMITTER: Cho A 

PROVIDER: S-EPMC6993391 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature